Mechanism-based PRNP-targeting and anti-PrP immunotherapy represent emerging strategies for prion disease management
New strategies target the core causes of prion disease
This narrative scoping review examines the shift toward mechanism-based strategies, including antisense oligonucleotides, siRNA, and anti-Pr…
Scientists are moving toward targeted therapies to stop the protein buildup and brain inflammation caused by prion disease.
PEG-IFN plus novel agents may boost functional cure in chronic hepatitis B
Combination therapies may improve functional cure rates for chronic hepatitis B
This narrative review examines combining pegylated interferon-α with novel immunotherapies (antigen-reduction strategies, therapeutic vaccin…
A review suggests combining pegylated interferon with new immunotherapies could help achieve functional cure in chronic hepatitis B patients…